CytoDyn (CYDY) Other Non-Current Assets (2009 - 2026)
CytoDyn (CYDY) posted Other Assets of $71,000 for fiscal Q1 2027 (quarter ended Aug 31, 2026), down 46.6% from $133,000 a year earlier and down 25.3% from the prior quarter.
CytoDyn (CYDY) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2026 (ended May 31, 2026), CytoDyn's Other Assets came in at $95,000, down 43.8% from FY2025.
- Annual Other Assets has declined for four consecutive fiscal years, with a four-year compound annual growth rate of -40.2% (FY2022 to FY2026).
- In prior fiscal years, CytoDyn's Other Assets was $169,000 in FY2025 (-47.4%), $321,000 in FY2024 (-34.1%), $487,000 in FY2023 (-34.3%) and $741,000 in FY2022.
- Quarterly Other Assets has run from a low of $59,000 in fiscal Q3 2026 to a high of $741,000 in fiscal Q4 2022 over five years.
- On a year-over-year basis, Other Assets has declined in each of the last 14 quarters, with an average decline of 50.6% over the last eight quarters.
- The year-over-year decline in Other Assets has ranged between 23.5% (fiscal Q2 2024) and 71.5% (fiscal Q3 2026) over the last five years.
- According to Business Quant data, Other Assets for the three prior fiscal quarters was $95,000 (Q4 2026), $59,000 (Q3 2026) and $96,000 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | CytoDyn | 334.50 Mn | 285.65 Mn | - | 71,000.00 |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 71,000.00 |
| May 31, 2026 | 95,000.00 |
| Feb 28, 2026 | 59,000.00 |
| Nov 30, 2025 | 96,000.00 |
| Aug 31, 2025 | 133,000.00 |
| May 31, 2025 | 169,000.00 |
| Feb 28, 2025 | 207,000.00 |
| Nov 30, 2024 | 244,000.00 |
| Aug 31, 2024 | 283,000.00 |
| May 31, 2024 | 321,000.00 |
| Feb 29, 2024 | 360,000.00 |
| Nov 30, 2023 | 400,000.00 |
| Aug 31, 2023 | 443,000.00 |
| May 31, 2023 | 487,000.00 |
| Feb 28, 2023 | 532,000.00 |
| Nov 30, 2022 | 523,000.00 |
| Aug 31, 2022 | 608,000.00 |
| May 31, 2022 | 741,000.00 |
| Feb 28, 2022 | 1.00 Mn |
| Aug 31, 2021 | 9,000.00 |
CytoDyn Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CYDY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();